Consumer Health

A significant decrease in the birth rate (per ‘000 population) in 2022 is expected to be followed by a marginal drop over 2023. The demand for assisted reproduction increased by around 15% in 2022, compared to the previous year. However, since this…

Over 2023, paediatric consumer health retail current value sales are expected to continue to grow healthily. On the other hand, retail volume development is projected to be marginal-to-moderate, with declines anticipated for paediatric acetaminophen…

The high sales growth being seen in paediatric consumer health in the Philippines is largely due to the country’s relatively high birth rate and the culture of not skimping when it comes to spending money on children. However, it should be noted that…

In the United Arab Emirates, there is wide knowledge of consumer health, due to the diverse make-up of the population. However, there are a significant number of parents who continue to be hesitant to give children over-the-counter medications due to…

Paediatric consumer health in the UK is witnessing another strong year of current value growth in 2023, albeit at a slower pace than 2022. The positive performance across both years has predominantly been driven by high growth for paediatric cough,…

It is evident that the average consumer has become more health-conscious since COVID-19, as seen through transformations in ingredient-focused product development in dermatologicals, alongside the rise of natural remedies and botanical compositions…

Paediatric vitamins and dietary supplements in Tunisia is experiencing remarkable growth in current value terms in 2023. This growth can be attributed to several factors, including the significant presence of both locally produced and imported…

In general, paediatric consumer health recorded strong retail volume growth during the early-to-mid-review period, with the outbreak of Coronavirus (COVID-19) in 2020 providing a particular fillip to demand. However, as the pandemic threat eased, the…

Value sales for paediatric consumer health continues to be low in Uruguay and in 2023 it is expected to register a slight decrease in constant value sales, as continuing rising prices cuts into profitability. Analgesics continues to account for most…

Uzbek parents are keen to prioritise the wellbeing of their children and have a strong propensity to invest in their health. This trend has been gathering pace over the review period especially during the challenging times of the COVID-19 pandemic…

Demand for paediatric consumer health remains strong and rising in 2023, driven by increasing attention to children’s overall health and wellbeing, and consistent consumer education in Vietnam. An increasing mindset of prevention is prompting some…

Consumer demand for personalised solutions is spreading across consumer goods and services, influenced by considerable improvements to technologies that can match consumers with outcomes, and experiences that address their wants and needs. This…

The market for personalised vitamins and dietary supplements is evolving rapidly, as improvements in technology and investments from larger companies are driving innovation and lowering prices. This is segmenting the market for personalised…

In 2021, Asia Pacific ranked first globally in terms of production output of pharmaceuticals and medical equipment, with a turnover of USD857 billion. Over 2021-2030, the region is expected to record the fastest production growth globally,…

In Western Europe, the preventative health trend was accelerated by consumers’ rising health concerns due to the 2020 global pandemic. This resulted in several product launches positioned under the immune boost and/or wellbeing umbrellas. This report…

Procter & Gamble has maintained its position in 2022. Growth has been driven by persistent consumer loyalty to well-known brands such as Vicks, Metamucil, Align and Neurobion. While North America is a key region, Western Europe and Latin America have…

Reckitt Benckiser (RB) has strengthened its position in 2022, gaining a place to become the world’s sixth largest consumer health company driven by strong performance in the US and the UK. Growth has been driven by brand development and customer…

New business models, channels and shopper expectations continue to change retail, redefining industry rules and relationships and disrupting the path to purchase. This content provides strategies for adapting to these shifts and offers a framework to…

Sanofi maintained fourth position in consumer health in 2022 , with its strong brands in analgesics and cough cold and allergy remedies positively affected by growing self-treatment during the pandemic and cold season. The ongoing strategic divesture…

During 2023, sleep aids continued to benefit from the post- pandemic landscape of ongoing global economic instability, compounded by rampant inflation, which placed pressure on both middle- and low-income groups. As a result, consumers were forced to…